Cell and Gene Commercialization

  1. Accelerate European Market Access With MAA Submission 6/3/2024

    Discover how ensuring preparedness for Marketing Authorization Application (MAA) approval can streamline your application process and subsequent follow-up.

  2. GMP Services To Support Commercial Development 5/30/2024

    Expedite your development with our comprehensive suite of GMP services specifically designed to streamline regulatory and get you to market faster.

  3. Cell And Gene Therapy Center Of Excellence 5/28/2024

    By collaborating with your team to proactively identify and mitigate potential risks at every stage, we can expedite your product development timeline and enhance your prospects for commercial success.

  4. 5 Key Challenges In The Development Of CGT 5/28/2024

    By tackling these challenges, organizations can greatly improve their chances of obtaining approval and successfully marketing their CAGT products, thereby advancing healthcare.

  5. 6 Key Elements Of Successful Drug And Device Development In Europe 5/28/2024

    Equip your team with the knowledge and strategies necessary to navigate the complexities of EMEA and country-specific regulations with confidence and clarity.

  6. Dr. Bruce Levine on ISCT and the Future of CAR-T 5/23/2024

    In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more.

  7. Dr. Bruce Levine On ISCT And The Future of CAR-T 5/23/2024

    In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more.

  8. Navigating CGT Commercialization: Key Areas For Success 5/13/2024

    The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.

  9. Gene Therapy: Global Market Trends & Notable Developments 5/8/2024

    New market research about the gene therapy market from Markets And Markets reveals insights into macro trends, delivery methods, therapeutic areas, and more.

  10. Pioneering The First Cell Therapy For Solid Tumors 4/26/2024

    I spoke to Iovance Biotherapeutics to learn about the company's preparation leading up to the approval of Amtagvi, the first FDA-approved tumor-infiltrating lymphocyte (TIL) therapy aimed at treating solid tumors.